| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |